Serum Amyloid A in Uremic HDL Promotes Inflammation
Open accessAbstract
Uremia impairs the atheroprotective properties of HDL, but the mechanisms underlying why this occurs are unknown. Here, we observed that HDL isolated from healthy individuals inhibited the production of inflammatory cytokines by peripheral monocytes stimulated with a Toll-like receptor 2 agonist. In contrast, HDL isolated from the majority of patients with ESRD did not show this anti-inflammatory property; many HDL samples even promoted the production of inflammatory cytokines. To investigate this difference, we used shotgun proteomics to identify 49 HDL-associated proteins in a uremia-specific pattern. Proteins enriched in HDL from patients with ESRD (ESRD-HDL) included surfactant protein B (SP-B), apolipoprotein C-II, serum amyloid A (SAA), and α-1-microglobulin/bikunin precursor. In addition, we detected some ESRD-enriched proteins in earlier stages of CKD. We did not detect a difference in oxidation status between HDL isolated from uremic and healthy patients. Regarding function of these uremia-specific proteins, only SAA mimicked ESRD-HDL by promoting inflammatory cytokine production. Furthermore, SAA levels in ESRD-HDL inversely correlated with its anti-inflammatory potency. In conclusion, HDL has anti-inflammatory activities that are defective in uremic patients as a result of specific changes in its molecular composition. These data suggest a potential link between the high levels of inflammation and cardiovascular mortality in uremia.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In patients with diabetes mellitus, coronary disease, chronic renal insufficiency, cardiovascular risk factors and disorders, the function of HDL is impaired.
“In patients with diabetes mellitus, coronary disease, chronic renal insufficiency, cardiovascular risk factors and disorders, the function of HDL is impaired [9, 61, 70–74].”
From HDL cholesterol: reappraisal of its clinical relevance (2017) · cites this paper as [73]
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633 · see citing works
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369 · see citing works
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,756 · see citing works
Chronic Kidney Disease and Mortality Risk
Tonelli, M. A., Wiebe, N., Culleton, B. F., House, A. A., Rabbat, C., Fok, M. N., McAlister, F. A., & Garg, A. X. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005101085 · Cited by 1,655 · see citing works
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474 · see citing works
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394 · see citing works
The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia
Himmelfarb, J., Stenvinkel, P., Ikizler, T. A., & Hakim, R. M. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00600.x · Cited by 1,179 · see citing works
Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci26206 · Cited by 942 · see citing works
The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
Weichhart, T., Costantino, G., Poglitsch, M., Rosner, M., Zeyda, M., Stuhlmeier, K. M., Kolbe, T., Stulnig, T. M., Hörl, W. H., Hengstschläger, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.012 · Cited by 801 · see citing works
Self-citationGoodkin, D. A., Bragg‐Gresham, J. L., Koenig, K. G., Wolfe, R. A., Akiba, T., Andreucci, V. E., Saitō, A., Rayner, H. C., Kurokawa, K., Port, F. K., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000100127.54107.57 · Cited by 756 · see citing works
Zheng, L., Nukuna, B. N., Brennan, M., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21109 · Cited by 735 · see citing works
Navab, M., Ananthramaiah, G. M., Reddy, S. T., Lenten, B. J. V., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S. Y., Hough, G., Kamranpour, N., et al. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r400001-jlr200 · Cited by 687 · see citing works
Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients
Kalantar‐Zadeh, K., Block, G., McAllister, C. J., Humphreys, M. H., & Kopple, J. D. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.2.299 · Cited by 628 · see citing works
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Vaziri, N. D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2005 · Cited by 542 · see citing works
Kalantar‐Zadeh, K., Regidor, D. L., Kovesdy, C. P., Wyck, D. V., Bunnapradist, S., Horwich, T. B., & Fonarow, G. C. (2009) · Circulation · doi:10.1161/circulationaha.108.807362 · Cited by 541 · see citing works
Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease
Muntner, P., He, J., Astor, B. C., Folsom, A. R., & Coresh, J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080656 · Cited by 490 · see citing works
Bowry, V. W., Stanley, K. K., & Stocker, R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10316 · Cited by 479 · see citing works
Self-citationBergt, C., Pennathur, S., Fu, X., Byun, J., O'Brien, K., McDonald, T. O., Singh, P., Anantharamaiah, G. M., Chait, A., Brunzell, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405292101 · Cited by 454 · see citing works
Davidson, W. S., Silva, R. A. G. D., Chantepie, S., Lagor, W. R., Chapman, M. J., & Kontush, A. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.186031 · Cited by 415 · see citing works
Detecting Differential and Correlated Protein Expression in Label-Free Shotgun Proteomics
Zhang, B., VerBerkmoes, N. C., Langston, M. A., Uberbacher, E. C., Hettich, R. L., & Samatova, N. F. (2006) · Journal of Proteome Research · doi:10.1021/pr0600273 · Cited by 394 · see citing works
Biomarkers of inflammation and progression of chronickidney disease
Tonelli, M. A., Sacks, F. M., Pfeffer, M. A., Jhangri, G. S., & Curhan, G. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00398.x · Cited by 358 · see citing works
Lipoprotein metabolism and lipid management in chronic kidney disease
Kwan, B. C. H., Kronenberg, F., Beddhu, S., & Cheung, A. K. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091006 · Cited by 354 · see citing works
Serum amyloid A induces IL-8 secretion through a G protein–coupled receptor, FPRL1/LXA4R
He, R., Sang, H., & Ye, R. D. (2003) · Blood · doi:10.1182/blood-2002-05-1431 · Cited by 329 · see citing works
Niemi, K., Teirilä, L., Lappalainen, J., Rajamäki, K., Baumann, M. H., Öörni, K., Wolff, H., Kovanen, P. T., Matikainen, S., & Eklund, K. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002843 · Cited by 298 · see citing works
Cutting Edge: TLR2 Is a Functional Receptor for Acute-Phase Serum Amyloid A
Cheng, N., He, R., Tian, J., Ye, P. P., & Ye, R. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.22 · Cited by 284 · see citing works
Oxidation of High Density Lipoproteins
Garner, B., Witting, P. K., Waldeck, A. R., Christison, J. K., Raftery, M. J., & Stocker, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.11.6080 · Cited by 278 · see citing works
Self-citationBeyond High-Density Lipoprotein Cholesterol Levels
deGoma, E. M., deGoma, R. L., & Rader, D. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.016 · Cited by 251 · see citing works
Gordon, S. M., Deng, J., Lu, L. J., & Davidson, W. S. (2010) · Journal of Proteome Research · doi:10.1021/pr100520x · Cited by 243 · see citing works
Karlsson, H., Leanderson, P., Tagesson, C., & Lindahl, M. G. (2005) · PROTEOMICS · doi:10.1002/pmic.200401010 · Cited by 240 · see citing works
Red Cells, Hemoglobin, Heme, Iron, and Atherogenesis
Nagy, E., Eaton, J. W., Jeney, V., Soares, M. P., Varga, Z., Galajda, Z., Szentmiklósi, J., Méhes, G., Csonka, T., Smith, A., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.206433 · Cited by 239 · see citing works
Association between Serum Lipids and Survival in Hemodialysis Patients and Impact of Race
Kilpatrick, R. D., McAllister, C. J., Kovesdy, C. P., Derose, S. F., Kopple, J. D., & Kalantar‐Zadeh, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070795 · Cited by 233 · see citing works
Haidinger, M., Poglitsch, M., Geyeregger, R., Kasturi, S. P., Zeyda, M., Zlabinger, G. J., Pulendran, B., Hörl, W. H., Säemann, M. D., & Weichhart, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000296 · Cited by 227 · see citing works
Self-citationOxidative stress in renal dysfunction: mechanisms, clinical sequelae and therapeutic options
Kao, M. P. C., Ang, D. S. C., Pall, A., & Struthers, A. D. (2009) · Journal of Human Hypertension · doi:10.1038/jhh.2009.70 · Cited by 221 · see citing works
The paradox of dysfunctional high-density lipoprotein
Ansell, B. J., Fonarow, G. C., & Fogelman, A. M. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282364a17 · Cited by 198 · see citing works
Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease
Moradi, H., Pahl, M. V., Elahimehr, R., & Vaziri, N. D. (2008) · Translational research · doi:10.1016/j.trsl.2008.11.007 · Cited by 194 · see citing works
Shao, B., Oda, M. N., Bergt, C., Fu, X., Green, P. S., Brot, N., Oram, J. F., & Heinecke, J. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c600011200 · Cited by 191 · see citing works
Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I
Shao, B., Cavigiolio, G., Brot, N., Oda, M. N., & Heinecke, J. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802025105 · Cited by 189 · see citing works
Is serum amyloid A an endogenous TLR4 agonist?
Sandri, S., Rodriguez, D., Gomes, E., Monteiro, H. P., Russo, M., & Campa, A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407203 · Cited by 188 · see citing works
High density lipoprotein: it's not just about lipid transport anymore
Gordon, S. M., Hofmann, S. M., Askew, D. S., & Davidson, W. S. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.10.001 · Cited by 174 · see citing works
Murine serum amyloid A3 is a high density apolipoprotein and is secreted by macrophages.
Meek, R. L., Eriksen, N., & Benditt, E. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.7949 · Cited by 174 · see citing works
Proteomic analysis of high‐density lipoprotein
Rezaee, F., Casetta, B., Levels, J. H. M., Speijer, D., & Meijers, J. C. M. (2006) · PROTEOMICS · doi:10.1002/pmic.200500191 · Cited by 174 · see citing works
Whitehead, A. S., de Beer, M. C., Steel, D. M., Rits, M., Lélias, J.-M., Lane, W. S., & de Beer, F. C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50605-6 · Cited by 171 · see citing works
HDL metabolism and activity in chronic kidney disease
Vaziri, N. D., Navab, M., & Fogelman, A. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.36 · Cited by 160 · see citing works
Suzuki, M., Pritchard, D. K., Becker, L., Hoofnagle, A. N., Tanimura, N., Bammler, T. K., Beyer, R. P., Bumgarner, R. E., Vaisar, T., de Beer, M. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.961193 · Cited by 143 · see citing works
Upston, J. M., Niu, X., Brown, A. J., Mashima, R., Wang, H., Senthilmohan, R., Kettle, A. J., Dean, R. T., & Stocker, R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64890-0 · Cited by 143 · see citing works
Self-citationPROGRESS IN UREMIC TOXIN RESEARCH: The Role of Oxidative Stress in Chronic Kidney Disease
Massy, Z. A., Stenvinkel, P., & Drüeke, T. B. (2009) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2009.00590.x · Cited by 134 · see citing works
HDL-inflammatory index correlates with poor outcome in hemodialysis patients
Kalantar‐Zadeh, K., Kopple, J. D., Kamranpour, N., Fogelman, A. M., & Navab, M. (2007) · Kidney International · doi:10.1038/sj.ki.5002491 · Cited by 130 · see citing works
Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome
Green, P. S., Vaisar, T., Pennathur, S., Kulstad, J. J., Moore, A. B., Marcovina, S. M., Brunzell, J. D., Knopp, R. H., Zhao, X.-Q., & Heinecke, J. W. (2008) · Circulation · doi:10.1161/circulationaha.108.770669 · Cited by 129 · see citing works
Karlsson, H., Leanderson, P., Tagesson, C., & Lindahl, M. G. (2005) · PROTEOMICS · doi:10.1002/pmic.200300938 · Cited by 126 · see citing works
Watanabe, J., Grijalva, V. R., Hama, S. Y., Barbour, K. W., Berger, F. G., Navab, M., Fogelman, A. M., & Reddy, S. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017202 · Cited by 117 · see citing works
High density lipoprotein oxidation: in vitro susceptibility and potential in vivo consequences
Francis, G. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00181-x · Cited by 114 · see citing works
Vaziri, N. D., Moradi, H., Pahl, M. V., Fogelman, A. M., & Navab, M. (2009) · Kidney International · doi:10.1038/ki.2009.177 · Cited by 113 · see citing works
The versatility of HDL: a crucial anti‐inflammatory regulator
Säemann, M. D., Poglitsch, M., Kopecky, C., Haidinger, M., Hörl, W. H., & Weichhart, T. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02361.x · Cited by 109 · see citing works
Self-citationValiyaveettil, M., Kar, N. S., Ashraf, M. Z., Byzova, T. V., Febbraio, M., & Podrez, E. A. (2007) · Blood · doi:10.1182/blood-2007-08-107813 · Cited by 108 · see citing works
Baranova, I. N., Bocharov, A. V., Vishnyakova, T. G., Kurlander, R. J., Chen, Z., Fu, D., Arias, I. M., Csákó, G., Patterson, A. P., & Eggerman, T. L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007526 · Cited by 106 · see citing works
Slany, A., Haudek, V. J., Zwickl, H., Gundacker, N. C., Grusch, M., Weiß, T. S., Seir, K., Rodgarkia‐Dara, C., Hellerbrand, C., & Gerner, C. (2009) · Journal of Proteome Research · doi:10.1021/pr900057t · Cited by 104 · see citing works
Self-citationKidney Disease and Cardiovascular Risk
Tonelli, M. A., & Pfeffer, M. A. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.58.071105.111123 · Cited by 87 · see citing works
Apolipoprotein A-IV Predicts Progression of Chronic Kidney Disease
Boes, E., Fliser, D., Ritz, E., König, P., Lhotta, K., Mann, J. F. E., Muller, G. A., Neyer, U., Riegel, W., Riegler, P., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070733 · Cited by 84 · see citing works
HDL in humans with cardiovascular disease exhibits a proteomic signature
Vaisar, T., Mayer, P. S., Nilsson, E. J., Zhao, X. Q., Knopp, R. H., & Prazen, B. J. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.023 · Cited by 80 · see citing works
Bin, L., Nielson, L. D., Liu, X., Mason, R. J., & Shu, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.924 · Cited by 77 · see citing works
Chronic kidney disease and life course socioeconomic status: A review
Shoham, D. A., Vupputuri, S. X., & Kshirsagar, A. V. (2005) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2004.10.007 · Cited by 71 · see citing works
Serum amyloid A may potentiate prothrombotic and proinflammatory events in acute coronary syndromes.
Song, C., Shen, Y., Yamen, E., Hsu, K. J., Yan, W.-X., Witting, P., Geczy, C., & Freedman, S. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.049 · Cited by 69 · see citing works
High Density Lipoproteins (HDL) and the Oxidative Hypothesis of Atherosclerosis
Bonnefont‐Rousselot, D., Thérond, P., Beaudeux, J., Peynet, J., Legrand, A., & Delattre, J. (1999) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.1999.139 · Cited by 68 · see citing works
The variability and accurate assessment of microinflammation in haemodialysis patients
Tsirpanlis, G. I., Bagos, P. G., Ioannou, D., Bleta, A., Μαρίνου, Ι., Lagouranis, A., Chatzipanagiotou, S., & Nicolaou, C. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg486 · Cited by 66 · see citing works
Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials
Chan, D. T., Irish, A. B., Dogra, G. K., & Watts, G. F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.01.023 · Cited by 65 · see citing works
Pankhurst, G. J., Wang, X. L., Wilcken, D. E. L., Baernthaler, G., Panzenboeck, U., Raftery, M. J., & Stocker, R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200256-jlr200 · Cited by 65 · see citing works
Self-citationInflammation in ESRD: Causes and potential consequences
Kaysen, G. A., & Kumar, V. (2003) · Journal of Renal Nutrition · doi:10.1053/jren.2003.50021 · Cited by 60 · see citing works
Pasquale, C. G. D., Arnolda, L., DOYLE, I. R., Aylward, P. E., Chew, D. P., & Bersten, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000140260.73611.fa · Cited by 60 · see citing works
Cytoplasmic Proteome and Secretome Profiles of Differently Stimulated Human Dendritic Cells
Gundacker, N. C., Haudek, V. J., Wimmer, H., Slany, A., Griss, J., Bochkov, V., Zielinski, C. C., Wagner, O. F., Stöckl, J., & Gerner, C. (2009) · Journal of Proteome Research · doi:10.1021/pr8011039 · Cited by 51 · see citing works
Self-citationHypochlorite-modified high-density lipoprotein acts as a sink for myeloperoxidase in vitro
Marsche, G., Furtmüller, P. G., Obinger, C., Sattler, W., & Malle, E. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn051 · Cited by 49 · see citing works
Lee, H. Y., Kim, M.-K., Park, K. S., Shin, E. H., Jo, S. H., Kim, S. D., Jo, E., Lee, Y.-N., Lee, C., Baek, S., et al. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.022103 · Cited by 49 · see citing works
Heller, M., Schlappritzi, E., Stalder, D., Nuoffer, J., & Haeberli, A. (2007) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m600326-mcp200 · Cited by 49 · see citing works
Dyslipidemia in chronic kidney disease: Causes and consequences
Kaysen, G. A. (2006) · Kidney International · doi:10.1038/sj.ki.5001979 · Cited by 46 · see citing works
Gordon, S. M., Durairaj, A., Lu, J. L., & Davidson, W. S. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-009-0069-9 · Cited by 35 · see citing works
Suc, I., Brunet, S., Mitchell, G. A., Rivard, G., & Levy, E. H. (2002) · Journal of Cell Science · doi:10.1242/jcs.00126 · Cited by 31 · see citing works
Honda, H., Ueda, M., Kojima, S., Mashiba, S., Suzuki, H., Hosaka, N., Hirai, Y., Nakamura, M., Nagai, H., Kato, N., et al. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06110809 · Cited by 27 · see citing works
Wimmer, H., Gundacker, N. C., Griss, J., Haudek, V. J., Stättner, S., Mohr, T. T., Zwickl, H., Paulitschke, V., Baron, D. M., Trittner, W., et al. (2009) · Electrophoresis · doi:10.1002/elps.200900072 · Cited by 23 · see citing works
Self-citationA sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL
Wang, X., Shao, B., Oda, M. N., Heinecke, J. W., Mahler, S. M., & Stocker, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d800042-jlr200 · Cited by 22 · see citing works
Self-citationLiver carboxylesterase cleaves surfactant protein (SP-) B and promotes surfactant subtype conversion
Ruppert, C., Bagheri, A., Markart, P., Schmidt, R., Seeger, W., & Günther, A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.013 · Cited by 13 · see citing works
Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients
Hirano, T., Nohtomi, K., Nakanishi, N., Watanabe, T., Hyodo, T., & Taira, T. (2010) · Clinical Nephrology · doi:10.5414/cnp74282 · Cited by 7 · see citing works
Why HDL cholesterol is ‘good cholesterol’
van der Giet, M., & Tölle, M. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01325.x · Cited by 1 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
The immune system and kidney disease: basic concepts and clinical implications
Kurts, C., Panzer, U., Anders, H., & Rees, A. J. (2013) · Nature reviews. Immunology · doi:10.1038/nri3523 · Cited by 704 · see citing works
HDL-targeted therapies: progress, failures and future
Kingwell, B. A., Chapman, M. J., Kontush, A., & Miller, N. E. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4279 · Cited by 354 · see citing works
SHAH, A. S., Tan, L., Long, J. L., & Davidson, W. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.r035725 · Cited by 352 · see citing works
High-density lipoproteins: A consensus statement from the National Lipid Association
Toth, P. P., Barter, P. J., Rosenson, R. S., Boden, W. E., Chapman, M. J., Cuchel, M., D'Agostino, R. B., Davidson, M. H., Davidson, W. S., Heinecke, J. W., et al. (2013) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2013.08.001 · Cited by 336 · see citing works
Anders, H., & Schaefer, L. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010117 · Cited by 328 · see citing works
HDL cholesterol: reappraisal of its clinical relevance
März, W., Kleber, M. E., Scharnagl, H., Speer, T., Zewinger, S., Ritsch, A., Parhofer, K. G., von Eckardstein, A., Landmesser, U., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1106-1 · Cited by 275 · see citing works
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences
Vaziri, N. D. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.026 · Cited by 248 · see citing works
Dysfunctional High-Density Lipoprotein in Patients on Chronic Hemodialysis
Yamamoto, S., Yancey, P. G., Ikizler, T. A., Jerome, W. G., Kaseda, R., Cox, B. E., Bian, A., Shintani, A., Fogo, A. B., Linton, M. F., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.013 · Cited by 196 · see citing works
Annema, W., & von Eckardstein, A. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-1025 · Cited by 182 · see citing works
Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations
Noels, H., Lehrke, M., Vanholder, R. C., & Jankowski, J. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00423-5 · Cited by 183 · see citing works
Immune Dysfunction in Uremia—An Update
Cohen, G., & Hörl, W. H. (2012) · Toxins · doi:10.3390/toxins4110962 · Cited by 177 · see citing works
Self-citationPsoriasis alters HDL composition and cholesterol efflux capacity
Holzer, M., Wolf, P., Ćurčić, S., Birner‐Gruenberger, R., Weger, W., Inzinger, M., El‐Gamal, D., Wadsack, C., Heinemann, Á., & Marsche, G. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m027367 · Cited by 173 · see citing works
Immune Dysfunction in Uremia 2020
Cohen, G. (2020) · Toxins · doi:10.3390/toxins12070439 · Cited by 172 · see citing works
HDL abnormalities in nephrotic syndrome and chronic kidney disease
Vaziri, N. D. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.180 · Cited by 167 · see citing works
Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk
Zewinger, S., Drechsler, C., Kleber, M. E., Dressel, A., Riffel, J., Triem, S., Lehmann, M., Kopecky, C., Säemann, M. D., Lepper, P. M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv352 · Cited by 150 · see citing works
Self-citationThe HDL Proteome Watch: Compilation of studies leads to new insights on HDL function
Davidson, W. S., SHAH, A. S., Sexmith, H., & Gordon, S. M. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.159072 · Cited by 138 · see citing works
Reiss, A. B., Voloshyna, I., Leon, J. D., Miyawaki, N., & Mattana, J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.06.028 · Cited by 133 · see citing works
Inflammation alters HDL composition and function: Implications for HDL-raising therapies
Marsche, G., Säemann, M. D., Heinemann, Á., & Holzer, M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.001 · Cited by 130 · see citing works
Self-citationAging affects high-density lipoprotein composition and function
Holzer, M., Trieb, M., Kónya, V., Wadsack, C., Heinemann, Á., & Marsche, G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.06.004 · Cited by 125 · see citing works
HDL in Children with CKD Promotes Endothelial Dysfunction and an Abnormal Vascular Phenotype
Shroff, R. C., Speer, T., Colin, S., Charakida, M., Zewinger, S., Staels, B., Chinetti, G., Hettrich, I., Rohrer, L., O’Neill, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111212 · Cited by 120 · see citing works
TLR4 is a link between diabetes and Alzheimer’s disease
Huang, N., Jin, H. D., Zhou, S., Shi, J., & Jin, F. J. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.047 · Cited by 119 · see citing works
Acute-phase protein synthesis: a key feature of innate immune functions of the liver
Ehlting, C., Wolf, S. D., & Bode, J. G. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0209 · Cited by 115 · see citing works
Moradi, H., Streja, E., Kashyap, M. L., Vaziri, N. D., Fonarow, G. C., & Kalantar‐Zadeh, K. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu022 · Cited by 109 · see citing works
The Changing Face of HDL and the Best Way to Measure It
Karathanasis, S. K., Freeman, L. A., Gordon, S. M., & Remaley, A. T. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.257725 · Cited by 109 · see citing works
Altered high-density lipoprotein composition and functions during severe COVID-19
Bègue, F., Tanaka, S., Mouktadi, Z., Rondeau, P., Veeren, B., Diotel, N., Tran‐Dinh, A., Robert, T., Vélia, E., Mavingui, P., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81638-1 · Cited by 105 · see citing works
HDL Cholesterol Is Not Associated with Lower Mortality in Patients with Kidney Dysfunction
Zewinger, S., Speer, T., Kleber, M. E., Scharnagl, H., Woitas, R., Lepper, P. M., Pfahler, K., Seiler, S., Heine, G. H., März, W., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050482 · Cited by 103 · see citing works
Distinct Proteomic Signatures in 16 HDL (High-Density Lipoprotein) Subspecies
Furtado, J. D., Yamamoto, R., Melchior, J., Andraski, A. B., Gamez-Guerrero, M., Mulcahy, P., He, Z., Cai, T., Davidson, W. S., & Sacks, F. M. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311607 · Cited by 102 · see citing works
Dialysis Modalities and HDL Composition and Function
Holzer, M., Schilcher, G., Ćurčić, S., Trieb, M., Ljubojević-Holzer, S., Stojaković, T., Scharnagl, H., Kopecky, C., Rosenkranz, A. R., Heinemann, Á., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014030309 · Cited by 100 · see citing works
Self-citationBirner‐Gruenberger, R., Schittmayer, M., Holzer, M., & Marsche, G. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.07.003 · Cited by 98 · see citing works
TLR4 mutant mice are protected from renal fibrosis and chronic kidney disease progression
Souza, A. C. P., Tsuji, T., Baranova, I. N., Bocharov, A. V., Wilkins, K. J., Street, J. M., Álvarez-Prats, A., Hu, X., Eggerman, T. L., Yuen, P. S. T., et al. (2015) · Physiological Reports · doi:10.14814/phy2.12558 · Cited by 99 · see citing works
Keane, W. F., Tomassini, J. E., & Neff, D. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12849 · Cited by 97 · see citing works
Rogacev, K. S., Zawada, A. M., Emrich, I. E., Seiler, S., Böhm, M., Fliser, D., Woollard, K. J., & Heine, G. H. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304172 · Cited by 96 · see citing works
Beginning to Understand High-Density Lipoproteins
Santos‐Gallego, C. G., Badimon, J. J., & Rosenson, R. S. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2014.08.001 · Cited by 95 · see citing works
HDL in CKD-The Devil Is in the Detail.
Kronenberg, F. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017070798 · Cited by 80 · see citing works
The Endothelium Is Both a Target and a Barrier of HDL’s Protective Functions
Robert, J., Osto, E., & von Eckardstein, A. (2021) · Cells · doi:10.3390/cells10051041 · Cited by 88 · see citing works
Liver disease alters high-density lipoprotein composition, metabolism and function
Trieb, M., Horvath, A., Birner‐Gruenberger, R., Spindelboeck, W., Stadlbauer, V., Taschler, U., Ćurčić, S., Stauber, R. E., Holzer, M., Pasterk, L., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.04.013 · Cited by 87 · see citing works
Toll-like receptors: sensing and reacting to diabetic injury in the kidney
Lin, M., & Tang, S. C. W. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft446 · Cited by 86 · see citing works
Qiu, C., Zhao, X., Zhou, Q., & Zhang, Z. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0604-5 · Cited by 84 · see citing works
Role of HDL Dysfunction in End-Stage Renal Disease: A Double-Edged Sword
Moradi, H., Vaziri, N. D., Kashyap, M. L., Said, H. M., & Kalantar‐Zadeh, K. (2013) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2013.01.022 · Cited by 81 · see citing works
HDL Cholesterol Efflux Capacity and Cardiovascular Events
Rohatgi, A., de Lemos, J. A., & Shaul, P. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1503139 · Cited by 81 · see citing works
Triolo, M., Annema, W., Dullaart, R. P. F., & Tietge, U. J. F. (2013) · Biomarkers in Medicine · doi:10.2217/bmm.13.35 · Cited by 71 · see citing works
Sun, J. T., Yang, K., Lu, L., Zhu, Z. B., Zhu, J. Z., Ni, J., Han, H., Chen, N., & Zhang, R. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00508.2015 · Cited by 71 · see citing works
Chang, T. I., Streja, E., Soohoo, M., Kim, T., Rhee, C. M., Kovesdy, C. P., Kashyap, M. L., Vaziri, N. D., Kalantar‐Zadeh, K., & Moradi, H. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08730816 · Cited by 67 · see citing works
Post-translational modifications in kidney diseases and associated cardiovascular risk
Noels, H., Jankowski, V., Schunk, S. J., Vanholder, R. C., Kalim, S., & Jankowski, J. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00837-x · Cited by 67 · see citing works
Lipoproteins in chronic kidney disease: from bench to bedside
Speer, T., Ridker, P. M., von Eckardstein, A., Schunk, S. J., & Fliser, D. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa1050 · Cited by 66 · see citing works
Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins
Trakaki, A., & Marsche, G. (2021) · Biomedicines · doi:10.3390/biomedicines9060587 · Cited by 63 · see citing works
Dysfunctional high-density lipoproteins in children with chronic kidney disease
Kaseda, R., Jabs, K. L., Hunley, T. E., Jones, D. P., Bian, A., Allen, R. M., Vickers, K. C., Yancey, P. G., Linton, M. F., Fazio, S., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.020 · Cited by 63 · see citing works
Kopecky, C., Genser, B., Drechsler, C., Krane, V., Kaltenecker, C. C., Hengstschläger, M., März, W., Wanner, C., Säemann, M. D., & Weichhart, T. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06560714 · Cited by 63 · see citing works
Self-citationHDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients
Kopecky, C., Ebtehaj, S., Genser, B., Drechsler, C., Krane, V., Antlanger, M., Kovarik, J. J., Kaltenecker, C. C., Parvizi, M., Wanner, C., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016030262 · Cited by 59 · see citing works
Self-citationIntercellular Communication Lessons in Heart Failure
Bang, C., Antoniades, C. A., Antonopoulos, A. S., Eriksson, U., Franssen, C., Hamdani, N., Lehmann, L., Moessinger, C., Mongillo, M., Muhl, L., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.399 · Cited by 57 · see citing works
Shao, B., de Boer, I. H., Tang, C., Mayer, P. S., Zelnick, L. R., Afkarian, M., Heinecke, J. W., & Himmelfarb, J. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00060 · Cited by 57 · see citing works
New Pandemic: Obesity and Associated Nephropathy
Sharma, I., Liao, Y., Zheng, X., & Kanwar, Y. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.673556 · Cited by 57 · see citing works
Deepening our understanding of HDL proteome
Ronsein, G. E., & Vaisar, T. (2019) · Expert Review of Proteomics · doi:10.1080/14789450.2019.1650645 · Cited by 57 · see citing works
OxInflammation in Rett syndrome
Pecorelli, A., Cervellati, C., Hayek, J., & Valacchi, G. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.07.015 · Cited by 56 · see citing works
Dou, F., Miao, H., Wang, J., Chen, L., Wang, M., Chen, H., Wen, A., & Zhao, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00053 · Cited by 56 · see citing works
Signal Transduction by HDL: Agonists, Receptors, and Signaling Cascades
Nofer, J. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-09665-0_6 · Cited by 55 · see citing works
High-Density Lipoprotein Carries Markers That Track With Recovery From Stroke
Plubell, D. L., Fenton, A. M., Rosário, S., Bergstrom, P., Wilmarth, P. A., Clark, W. M., Zakai, N. A., Quinn, J. F., Minnier, J., Alkayed, N. J., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316526 · Cited by 54 · see citing works
High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?
Márquez, A. B., Nazir, S., & van der Vorst, E. P. C. (2020) · Biomedicines · doi:10.3390/biomedicines8120549 · Cited by 53 · see citing works
Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein
Kon, V., Yang, H., & Fazio, S. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.009 · Cited by 53 · see citing works
Shao, B., & Heinecke, J. W. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1402680 · Cited by 53 · see citing works
Kidney function is associated with an altered protein composition of high-density lipoprotein
Rubinow, K. B., Henderson, C. M., Robinson‐Cohen, C., Himmelfarb, J., de Boer, I. H., Vaisar, T., Kestenbaum, B. R., & Hoofnagle, A. N. (2017) · Kidney International · doi:10.1016/j.kint.2017.05.020 · Cited by 52 · see citing works
HDL proteome remodeling associates with COVID-19 severity
Souza, D. R., da Silva, A. R. M., Rosa-Fernandes, L., Reis, L. R., Alexandria, G., Bhosale, S. D., Ghilardi, F., Dalçóquio, T. F., Bertolin, A. J., Nicolau, J. C., et al. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.10.005 · Cited by 51 · see citing works
Lee, M. J., Park, J. T., Han, S. H., Kim, Y.-L., Kim, Y. S., Yang, C. W., Kim, N.-H., Kang, S., Kim, H. J., & Yoo, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177499 · Cited by 49 · see citing works
The role of high-density lipoproteins in the regulation of angiogenesis
Tan, J. T. M., Ng, M., & Bursill, C. A. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv104 · Cited by 48 · see citing works
Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
Salazar, J. J., Olivar, L. C., Ramos, E., Chávez-Castillo, M., Rojas, J., & Bermúdez, V. (2015) · Cholesterol · doi:10.1155/2015/296417 · Cited by 48 · see citing works
High-density lipoproteins are a potential therapeutic target for age-related macular degeneration
Kelly, U., Grigsby, D., Cady, M. A., Landowski, M., Skiba, N. P., Liu, J., Remaley, A. T., Klingeborn, M., & Rickman, C. B. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012305 · Cited by 46 · see citing works
Altered vitamin K biodistribution and metabolism in experimental and human chronic kidney disease
Kaesler, N., Schreibing, F., Speer, T., de la Puente-Secades, S., Rapp, N., Drechsler, C., Kabgani, N., Kuppe, C., Boor, P., Jankowski, V., et al. (2021) · Kidney International · doi:10.1016/j.kint.2021.10.029 · Cited by 46 · see citing works
Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention
Ossoli, A., Pavanello, C., Giorgio, E., Calabresi, L., & Gomaraschi, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180316115726 · Cited by 45 · see citing works
Uraemic dyslipidaemia revisited: role of high-density lipoprotein
Speer, T., Zewinger, S., & Fliser, D. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft080 · Cited by 44 · see citing works
High-Density Lipoproteins and the Kidney
Strazzella, A., Ossoli, A., & Calabresi, L. (2021) · Cells · doi:10.3390/cells10040764 · Cited by 43 · see citing works
The vulnerable patient with chronic kidney disease
Schlieper, G., Hess, K., Floege, J., & Marx, N. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv041 · Cited by 42 · see citing works
The effect of chronic kidney disease on lipid metabolism
Di̇nçer, N., Dağel, T., Afşar, B., Covic, A. C., Ortíz, A., & Kanbay, M. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-2047-y · Cited by 42 · see citing works
Restoration of Renal Function Does Not Correct Impairment of Uremic HDL Properties
Kopecky, C., Haidinger, M., Birner‐Gruenberger, R., Darnhofer, B., Kaltenecker, C. C., Marsche, G., Holzer, M., Weichhart, T., Antlanger, M., Kovarik, J. J., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013111219 · Cited by 41 · see citing works
Self-citationGenetic variants in CETP increase risk of intracerebral hemorrhage
Anderson, C. D., Falcone, G. J., Phuah, C., Radmanesh, F., Brouwers, H. B., Battey, T. W. K., Biffi, A., Peloso, G. M., Liu, D. J., Ayres, A. M., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24780 · Cited by 40 · see citing works
Marsche, G., Heine, G. H., Stadler, J. T., & Holzer, M. (2020) · Biomolecules · doi:10.3390/biom10091348 · Cited by 40 · see citing works
The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality
Prüfer, N., Kleuser, B., & van der Giet, M. (2014) · Biological Chemistry · doi:10.1515/hsz-2014-0192 · Cited by 40 · see citing works
The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis
Yu, M., Tsai, S., & Kuo, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061260 · Cited by 39 · see citing works
HDL and chronic kidney disease
Pavanello, C., & Ossoli, A. (2023) · Atherosclerosis Plus · doi:10.1016/j.athplu.2023.04.001 · Cited by 37 · see citing works
Emmens, J. E., Jones, D. J. L., Cao, T. H., Chan, D. C. S., Romaine, S. P. R., Quinn, P. A., Anker, S. D., Cleland, J. G. F., Dickstein, K., Filippatos, G. S., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1101 · Cited by 37 · see citing works
Shao, B., Zelnick, L. R., Wimberger, J., Himmelfarb, J., Brunzell, J. D., Davidson, W. S., Snell‐Bergeon, J. K., Bornfeldt, K., de Boer, I. H., & Heinecke, J. W. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312556 · Cited by 37 · see citing works
Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism
Schaefer, E. J. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283612454 · Cited by 34 · see citing works
Holzer, M., Kern, S., Birner‐Gruenberger, R., Ćurčić, S., Heinemann, Á., & Marsche, G. (2016) · Scientific Reports · doi:10.1038/srep38533 · Cited by 34 · see citing works
Schuchardt, M., Prüfer, N., Tu, Y., Herrmann, J., Hu, X., Chebli, S., Dahlke, K., Zidek, W., van der Giet, M., & Tölle, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-39846-3 · Cited by 33 · see citing works
Self-citationMaeba, R., Kojima, K., Nagura, M., Komori, A., Nishimukai, M., Okazaki, T., & Uchida, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.01.037 · Cited by 32 · see citing works
HDL functionality and cardiovascular outcome among nondialysis chronic kidney disease patients [S]
Untersteller, K., Meissl, S., Trieb, M., Emrich, I. E., Zawada, A. M., Holzer, M., Knuplez, E., Fliser, D., Heine, G. H., & Marsche, G. (2018) · Journal of Lipid Research · doi:10.1194/jlr.p085076 · Cited by 30 · see citing works
Locatelli, F., Spasovski, G. B., Dimkovic, N. B., Wanner, C., Dellanna, F., & Pontoriero, G. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft476 · Cited by 29 · see citing works
Belmokhtar, K., Robert, T., Ortillon, J., Braconnier, A., Vuiblet, V., Boulagnon‐Rombi, C., Diébold, M.-D., Piétrement, C., Schmidt, A. M., Rieu, P., et al. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306349 · Cited by 29 · see citing works
Concepts and Controversies: Lipid Management in Patients with Chronic Kidney Disease
Mathew, R. O., Rosenson, R. S., Lyubarova, R., Chaudhry, R., Costa, S. P., Bangalore, S., & Sidhu, M. S. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07020-x · Cited by 28 · see citing works
Marsche, G., Stadler, J. T., Kargl, J., & Holzer, M. (2022) · Antioxidants · doi:10.3390/antiox11030556 · Cited by 29 · see citing works
Altered HDL proteome predicts incident CVD in chronic kidney disease patients
Shao, B., Mathew, A. V., Thornock, C., Pennathur, S., Kretzler, M., Gipson, D. S., Bitzer, M., Gadegbeku, C. A., Bellovich, K. A., Bhat, Z. Y., et al. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100135 · Cited by 28 · see citing works
Effect of chronic kidney disease on macrophage cholesterol efflux
Meier, S. M., Wultsch, A., Hollaus, M., Ammann, M., Pemberger, E., Liebscher, F., Lambers, B., Fruhwürth, S., Stojaković, T., Scharnagl, H., et al. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.06.005 · Cited by 28 · see citing works
Hesse, B., Rovas, A., Buscher, K., Kusche‐Vihrog, K., Brand, M., Marco, G. S. D., Kielstein, J. T., Pavenstädt, H., Linke, W. A., Nofer, J., et al. (2019) · Kidney International · doi:10.1016/j.kint.2019.10.017 · Cited by 28 · see citing works
Leukocyte–endothelial interaction in CKD
Sarakpi, T., Mesic, A., & Speer, T. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad135 · Cited by 27 · see citing works
Cardioprotective Properties of HDL: Structural and Functional Considerations
Pappa, E. T., Elisaf, M., Kostara, C. E., Bairaktari, E. T., & Tsimihodimos, V. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190201142321 · Cited by 27 · see citing works
Could high-density lipoprotein cholesterol predict increased cardiovascular risk?
Chang, T. I., Streja, E., & Moradi, H. (2017) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000318 · Cited by 26 · see citing works
Kaseda, R., Tsuchida, Y., Yang, H.-C., Yancey, P. G., Zhong, J., Tao, H., Bian, A., Fogo, A. B., Linton, M. F., Fazio, S., et al. (2018) · BMC Nephrology · doi:10.1186/s12882-018-0814-8 · Cited by 26 · see citing works
Xu, Z., Yang, S., & Cui, L. (2024) · BMC Nephrology · doi:10.1186/s12882-024-03808-3 · Cited by 27 · see citing works
Kidney as modulator and target of “good/bad” HDL
Zhong, J., Yang, H., & Kon, V. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-4104-2 · Cited by 25 · see citing works
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Abrahams, C., Woudberg, N. J., & Lecour, S. (2022) · Lipids in Health and Disease · doi:10.1186/s12944-022-01694-y · Cited by 25 · see citing works
Rysz-Górzyńska, M., & Banach, M. (2016) · Archives of Medical Science · doi:10.5114/aoms.2016.60971 · Cited by 25 · see citing works
- Authors
- Weichhart, T., Kopecky, C., Kubicek, M., Haidinger, M., Döller, D., Katholnig, K., Suarna, C., Eller, P., Tölle, M., Gerner, C., Zlabinger, G. J., van der Giet, M., Hörl, W. H., Stocker, R., & Säemann, M. D.
- Affiliations
- Medical University of Vienna (AT)
- The University of Sydney (AU)
- Medical University of Graz (AT)
- Charité – Universitätsmedizin Berlin (DE)
- Comprehensive Cancer Center Vienna (AT)
- Corresponding author
- Weichhart, Thomas
- Kopecky, Chantal
- Haidinger, Michael
- Döller, Dominik
- Katholnig, Karl
- Zlabinger, Gerhard J.
- Hörl, Walter H.
- Säemann, Marcus D.
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2012-05
- Volume
- 23
- Issue
- 5
- Pages
- 934-947
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC3338291
- OpenAlex
- W2139976637
- Cited by
- 201
- References
- 81
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 13 · 2021: 18 · 2020: 11 · 2019: 15 · 2018: 17 · 2017: 20 · 2016: 17 · 2015: 22 · 2014: 21 · 2013: 18 · 2012: 6
- FWCI
- 16.92
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- serum amyloid A, end-stage renal disease, HDL dysfunction, inflammation, inflammatory cytokines, TLR2, monocytes, HDL-associated proteins, surfactant protein B, apolipoprotein C-II, alpha1-microglobulin, HDL oxidation, chronic kidney disease, cardiovascular mortality
- MeSH terms
- Adult, Aged, Serum Amyloid A Protein, Female, Humans, Inflammation, Iron, Kidney Failure, Chronic, Lipoproteins, HDL, Male, Middle Aged, Oxidation-Reduction, Uremia, Pulmonary Surfactant-Associated Protein B, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
